SCHEMBL2567422

SCHEMBL2567422

CCCCn1cc(NC(=O)Nc2ccc(OC(F)F)cc2)nc1OC(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.40
MMP9 P14780 1/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
HTT P42858 3/20 0.39
LMNA P02545 3/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ALDH1A1 P00352 5/20 0.38
MAPK1 P28482 2/20 0.37
AURKA O14965 2/20 0.37
MAP4K4 O95819 2/20 0.37
ABL1 P00519 2/20 0.37
NTRK1 P04629 2/20 0.37
LCK P06239 2/20 0.37
FYN P06241 2/20 0.37
CSF1R P07333 2/20 0.37
RET P07949 2/20 0.37
IGF1R P08069 2/20 0.37
MET P08581 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2565379 0.87 EPHX2 (0.49) MAPTALDH1A1IGF1RNPC1RAB9A
SCHEMBL1595262 0.87 MAPT (0.42) MAPTMMP9MEN1KMT2ASMN1; SMN2
SCHEMBL4069869 0.85 MAPT (0.44) MAPTMEN1KMT2ASMN1; SMN2HTT
SCHEMBL2570538 0.84 MEN1 (0.45) MAPTMEN1KMT2ASMN1; SMN2HTT
SCHEMBL2571142 0.78 EPHX2 (0.54) MAPTKMT2AALDH1A1IGF1RNPC1
SCHEMBL13197985 0.77 SMN1; SMN2 (0.42) MAPTMEN1KMT2ASMN1; SMN2HTT
SCHEMBL13197990 0.77 MAPK14 (0.37) MAPTMMP9MEN1KMT2ASMN1; SMN2
SCHEMBL2571501 0.76 EPHX2 (0.49) ALDH1A1IGF1RNPC1RAB9A
SCHEMBL1595469 0.75 EPHX2 (0.51) MAPTIGF1RNPC1RAB9A
SCHEMBL1594762 0.74 MAPT (0.46) MAPTMEN1KMT2ASMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1732901-B1 ANTIVIRAL 4-AMINOCARBONYLAMINO-SUBSTITUTED IMIDAZOLE COMPOUND AICURIS GMBH & CO KG (DE) 2011-11-02 EP disclosed
EP-1853582-B1 HETEROCYCLYLAMIDE-SUBSTITUTED IMIDAZOLES AICURIS GMBH & CO KG (DE) 2009-10-21 EP disclosed
EP-1853582-A2 HETEROCYCLYLAMIDE-SUBSTITUTED IMIDAZOLES AiCuris GmbH & Co. KG (DE) 2007-11-14 EP disclosed
EP-1732901-A1 ANTIVIRAL 4-AMINOCARBONYLAMINO-SUBSTITUTED IMIDAZOLE COMPOUND Bayer HealthCare AG (DE) 2006-12-20 EP disclosed
WO-2006089664-A2 HETEROCYCLYLAMIDE-SUBSTITUTED IMIDAZOLES AICURIS GMBH & CO. KG (DE) 2006-08-31 WO disclosed
WO-2005092865-A1 ANTIVIRAL 4-AMINOCARBONYLAMINO-SUBSTITUTED IMIDAZOLE COMPOUND BAYER HEALTHCARE AG (DE) 2005-10-06 WO disclosed